Anti-IL-33 antibody [Nessy-1] (ab54385)

Mouse monoclonal IL-33 antibody [Nessy-1]. Validated in WB, IP, ELISA, IHC and tested in Mouse, Human. Cited in 7 publication(s). Independently reviewed in 2 review(s).

Publishing research using ab54385? Please let us know so that we can cite the reference in this datasheet.

ab54385 has been referenced in 7 publications.

  • Luo Q  et al. Interleukin-33 Protects Ischemic Brain Injury by Regulating Specific Microglial Activities. Neuroscience 385:75-89 (2018). PubMed: 29906552
  • Yang Y  et al. Hepatoprotective Effect of San-Cao Granule on Con A-Induced Liver Injury in Mice and Mechanisms of Action Exploration. Front Pharmacol 9:624 (2018). PubMed: 29946260
  • Ni Y  et al. Dephosphorylated Polymerase I and Transcript Release Factor Prevents Allergic Asthma Exacerbations by Limiting IL-33 Release. Front Immunol 9:1422 (2018). PubMed: 29977243
  • Yang Y  et al. ST2/IL-33-Dependent Microglial Response Limits Acute Ischemic Brain Injury. J Neurosci 37:4692-4704 (2017). IHC-FrFl ; Mouse . PubMed: 28389473
  • Saranchova I  et al. Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33. Sci Rep 6:30555 (2016). WB . PubMed: 27619158
  • Deng K  et al. Tristetraprolin inhibits gastric cancer progression through suppression of IL-33. Sci Rep 6:24505 (2016). WB . PubMed: 27074834
  • Fu AK  et al. IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline. Proc Natl Acad Sci U S A 113:E2705-13 (2016). ELISA ; Mouse . PubMed: 27091974

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
For licensing inquiries, please contact partnerships@abcam.com

Sign up